Condition: Anesthesia · Sponsor: Haisco Pharmaceutical Group Co., Ltd.
This study is a multi-center (each center independently conducts the study according to the same research protocol), randomized, and open-label clinical study. The main objective is to verify and optimize the accuracy of the target-controlled infusion model of cipepofol.
This description comes directly from the study's public registry record.
Gao Jingui, Doctor · 15803210586 · gaojingui@126.com
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Chengde Medical University | Chengde, Hebei, China | Not Yet Recruiting |
| The Second Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06740201